Real-time enrollment status for this advanced cancer clinical trial
Current Status
Recruiting
Checked: April 18, 2026 at 12:23 AM UTC
| NCT Number | NCT06060613 |
| Recruiting Status | Recruiting |
| Condition | Advanced Cancer |
| Phase | Clinical Trial |
| Target Enrollment | 52 participants |
| Active Locations | 9 sites in the US |
| Sponsor | Obsidian Therapeutics, Inc. |
| Last Updated on CT.gov | March 27, 2026 (3 weeks ago) |
As of April 18, 2026: Clinical trial NCT06060613 is currently recruiting participants. This clinical trial study for advanced cancer is actively seeking new participants at 9 locations across the United States. The study is sponsored by Obsidian Therapeutics, Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06060613 is actively recruiting participants as of April 18, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 9 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06060613 was last updated 3 weeks ago (March 27, 2026). HelloStudys verifies this status automatically.